Skip to main content
Clinical Trials/EUCTR2012-005068-82-NL
EUCTR2012-005068-82-NL
Active, not recruiting
Not Applicable

An alternative approach for treatment of infantile esotropia with botulinum toxin A. - Botox in infantile esotropia.

The Rotterdam Eye Hospital0 sites40 target enrollmentNovember 19, 2012
DrugsBotox

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
The Rotterdam Eye Hospital
Enrollment
40
Status
Active, not recruiting
Last Updated
13 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 19, 2012
End Date
TBD
Last Updated
13 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
The Rotterdam Eye Hospital

Eligibility Criteria

Inclusion Criteria

  • \- Infantile esotropia; age \< 4 years,
  • \- No known/established neurological disease.
  • \- Onset of esotropia before 6 months without paralytic component.
  • \- No vertical deviation (no upshoots).
  • \- Non\-accommodative (less than 3D spherical equivalent hyperopia).
  • \- Up to 40 ? esotropia.
  • \- Free alternators.
  • \- Difference in refraction between both eyes \= 1\.5 D.
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 40

Exclusion Criteria

  • \- Previous strabismus surgery.
  • \- Retinal disease.
  • \- Any medical condition that would preclude general anesthesia with sevoflurane.

Outcomes

Primary Outcomes

Not specified

Similar Trials